OsimertinibAcquired resistance to osimertinib leading to transformation of lung adenocarcinoma to small cell lung carcinoma: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1654卷 / 1期

关键词：

D O I：

10.1007/s40278-017-30998-y

中图分类号：

学科分类号：

摘要：

引用

页码：265 / 265

共 50 条

[21] Transformation of lung adenocarcinoma treated with afatinib into small-cell carcinoma - a case report
Misztal, Monika
Krakowska, Magdalena
Sliwa, Mariusz
Potemski, Piotr
ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (03): : 140 - 142
[22] OsimertinibOsimertinib resistance and transformation from adenocarcinoma to small cell lung cancer: case report
Reactions Weekly, 2020, 1791 (1) : 203 - 203
[23] Afatinib/erlotinibMalignant transformation of lung adenocarcinoma to neuroendocrine/ small cell carcinoma following drug resistance: case report
Reactions Weekly, 2020, 1787 (1) : 22 - 22
[24] Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
Leonetti, Alessandro
Minari, Roberta
Mazzaschi, Giulia
Gnetti, Letizia
La Monica, Silvia
Alfieri, Roberta
Campanini, Nicoletta
Verze, Michela
Olivani, Andrea
Ventura, Luigi
Tiseo, Marcello
FRONTIERS IN ONCOLOGY, 2021, 11
[25] Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report
Wang, Diming
Ye, Wei
Chen, Dongmei
Shi, Qingming
Ma, Dongchun
CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 803 - 808
[26] GefitinibDevelopment of acquired resistance to gefitinib with transformation of lung adenocarcinoma to metastatic small cell lung cancer: case report
Reactions Weekly, 2022, 1899 (1) : 198 - 198
[27] GefitinibTransformation of lung adenocarcinoma to small cell carcinoma: case report
Reactions Weekly, 2015, 1579 (1) : 200 - 200
[28] GefitinibGefitinib resistance and transformation from lung adenocarcinoma to squamous cell carcinoma leading to fatal leptomeningeal neoplastic dissemination: case report
Reactions Weekly, 2017, 1644 (1) : 138 - 138
[29] OsimertinibAcquired resistance to osimertinib therapy: case report
Reactions Weekly, 2018, 1707 (1) : 217 - 217
[30] Erlotinib/gefitinibDevelopment of resistance as a transformation of lung adenocarcinoma to large cell neuroendocrine carcinoma: case report
Reactions Weekly, 2017, 1671 (1) : 185 - 185

← 1 2 3 4 5 →